CONTROL OF TGF-BETA RECEPTOR EXPRESSION IN BONE

Michael Centrella, Changhua Ji, Thomas L. McCarthy

Department of Surgery, Plastic Surgery Section, Yale University School of Medicine, 333 Cedar Street, PO Box 208041, New Haven, CT 06520-8041,

Received 12/1/97 Accepted 12/5/97

14. REFERENCES

1. Rodan, G. A. & T. J. Martin: Role of osteoblasts in hormonal control of bone resorption-a hypothesis. Calc. Tiss. Int. 33, 349-351 (1981)

2. Martin, T.J., K.W. Ng, & T. Suda: Bone cell physiology. Endocr. and Metab. Clin. North Am. 18, 833-858 (1989)

3. Teitelbaum, S.L.: Molecular defects of bone development. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. Ed. Fauvus, M.J. , Raven Press, NY. 2nd edition, 10-15 (1993)

4. Raisz, L.G.: Local and systemic factors in the pathogenesis of osteoporosis. N. Engl. J. Med. 318, 818-828 (1988)

5. Centrella, M., T.L. McCarthy, E. Canalis: Growth factors and cytokines. In: Bone: Bone metabolism and mineralization. Ed. B.K. Hall, editor, CRC Press Inc., Boca Raton , FL, volume 4, 47-72 (1992)

6. Mundy, G.R. (1993) Bone resorbing cells. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. Ed. Fauvus, M.J. , Raven Press, NY. 2nd edition, 25-32 (1993)

7. Hauschka, P.V., A.E. Mavrakos, M.D. Iafrati, S.E. Doleman, & M. Klagsbrun: Growth factors in bone matrix: isolation of multiple types by affinity chromatography on heparin sepharose. J. Biol. Chem. 261, 12665-12674 (1986)

8. Linkhart, T.A., J.C. Jennings, S. Mohan, G.K. Wakley & D.J. Baylink: Characterization of mitogenic activities extracted from bovine bone matrix. Bone 7, 479-487 (1986)

9. Pfeilschifter, J. & G.R. Mundy: Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. USA 84, 2024-2028 (1987)

10. Petkovich, P.M., J.L. Wrana, A.E. Grigoriadis, J.N.M. Heersche & J. Sodek: 1,25 dihydroxyvitamin D3 increases epidermal growth factor receptors and transforming growth factor beta-like activity in a bone-derived cell line. J. Biol. Chem. 262, 13424-13428 (1987)

11. Centrella, M., T.L. McCarthy & E. Canalis: Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblastic cells. Proc. Natl. Acad. Sci. USA 85, 5889-5893 (1988)

12. Komm, B.S., C.M. Terpening, D.J. Benz, K.A. Graeme, A. Gallegos, M. Korc, G.L. Greene , B.W. O'Malley & M.R. Haussler: M.R. Estrogen binding receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 241, 81-84 (1988)

13. McCarthy, T.L., M. Centrella, & E. Canalis: Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124, 1247-1253 (1989)

14. Centrella, M., T.L. McCarthy & E. Canalis: beta2-Microglobulin (beta2m) enhances insulin-like growth factor I binding and synthesis in bone cell cultures. J. Biol. Chem. 264, 18268-18271 (1989)

15. McCarthy, T.L., M. Centrella & E. Canalis: Cortisol inhibits the synthesis of insulin-like growth factor I in bone cell cultures. Endocrinology 126, 1569-1575 (1990)

16. Marusic, A., J.F. Kalinowski, J.R. Harrison, M. Centrella, L.G. Raisz & J.A. Lorenzo: Effects of transforming growth factor beta and interleukin 1 on prostaglandin synthesis in serum-deprived osteoblastic cells. J. Immunol. 146, 2633-2638 (1991)

17. McCarthy, T.L., E. Canalis & M. Centrella: Cortisol differentially modulates insulin-like growth factor I and II binding on osteoblast-enriched fetal rat bone cells. J. Bone Miner. Res. 5, abstract S138 (1990)

18. Chen, T.L., L.Y. Chang, R.L. Bates & A. Perlman: Dexamethasone and 1,25-dihydroxyvitamin D3 modulation of insulin-like growth factor binding proteins in rat osteoblast-like cell cultures. Endocrinology 128, 73-80 (1991)

19. Centrella, M., T.L. McCarthy & E. Canalis: Glucocorticoid regulation of transforming growth factor beta1 (TGF-beta1) activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol. Cell. Biol. 11, 4490-4496 (1991)

20. Centrella, M., V. Rosen, M.C. Horowitz, J.M. Wozney & T.L. McCarthy: Transforming growth factor-b gene family members, their receptors, and bone cell function. In: Hormonal regulation of bone mineral metabolism. Eds. Bikle, D.D. , Nego-Vilar, A., Endocrine Society Press, Bethesda MD. 211-226 (1995)

21. Centrella, M., J. Kim, T. Pham, S. Casinghino, V. Rosen, J. Wozney & T.L. McCarthy: Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein-2 parallel expression of the osteoblast phenotype. Mol. Cell. Biol. 15, 3273-3281 (1995)

22. Celeste, A.J., J.A. Ianazzi, R.C. Taylor, R.M. Hewick, V. Rosen, E.A. Wang & J.M. Wozney: Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA 87, 9843-9847 (1990)

23. Centrella, M., T.L. McCarthy & E. Canalis: Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal rat parietal bone. Mol. Cell. Biol. 11, 250-258 (1991)

24. Ogawa, Y., D.K. Schmidt, R.M. Nathan, R.M. Armstrong, K.L. Miller, S.J. Sawamura, J.M. Ziman, K.L. Erickson, E.R. deLeon, D.M. Rosen, S.M. Seyedin, C.B. Glaser, Chang, R.-J. Chang, A.Z. Corrigan & W.W. Vale: Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. J. Biol. Chem. 267, 14233-14237 (1992)

25. Roberts, V.J. , P.E. Sawchenko & W. Vale: Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology 128, 3122-3129 (1991)

26. Roberts A.B., & M.B. Sporn: Transforming growth factor betas. In : Peptide growth factors and their receptors,. Eds. Sporn, M.B., Roberts, A.B.. Springer-Verlag, Heidelberg, Germany. 419-472 (1990)

27. Ogawa, Y., D.K. Schmidt, J.R. Dasch, R.-J. Chang & C.B. Glaser: Purification and characterization of transforming growth factor-beta2.3 and 1.2 heterodimers from bovine bone. J. Biol. Chem. 267, 2325-2328 (1992)

28. Bonewald, L.F., L. Wakefield, R.O.C. Oreffo, A. Escobedo, D.R. Twardzik & G.R. Mundy: Latent forms of transforming growth factor-beta (TGFbeta) derived from bone cultures: identification of a naturally occurring 100 kDa complex with similarity to recombinant latent TGFbeta. Molec. Endocrinol. 6, 741-751 (1991)

29. Gibson, M.A., G. Hatzinikolas, E.C. Davis, E. Baker, E., G.R. Sutherland & R.P. Mecham: Bovine latent transforming growth factor beta1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol. Cell. Biol. 15, 6932-6942 (1995)

30. Baron, R., L. Neff, I. Louvard & P.J. Courtoy: Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kd lysosomal membrane protein at the osteoclast ruffled border. J. Cell Biol. 101, 2210-2222 (1985)

31. Massague, J., L. Attisano & J.L. Wrana: The TGF-beta family and its composite receptors. Trends. Cell. Biol. 4, 72-178 (1994)

32. Laiho, M., F.M.B. Weis & J. Massague: Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265, 18518-18524 (1990)

33. Lin, H.Y., X.-F. Wang, E. Ng-Eaton, R.A. Weinberg & H.F. Lodish: Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785 (1992)

34. Ohtsuki, M. & J. Massague: Evidence for the involvement of protein kinase activity in transforming growth factor-beta signal transduction. Mol. Cell. Biol. 12, 261-265 (1992)

35. Wrana, J.L., L. Attisano, R. Wieser, F. Ventura & J. Massague: Mechanism of activation of the TGF-beta receptor. Nature (London) 370, 341-347 (1994)

36. Ebner, R., H.-W. Chen, L. Shum, S. Lawler, T.F. Zioncheck, A. Lee, A.R. Lopez & R. DeRynck: Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science 260, 1344-1348 (1993)

37. Segarini, P.R. & S.M. Seyedin: The high molecular weight receptor to transforming growth factor -beta contains glycosamino glycan chains. J. Biol. Chem. 263, 8366-8370 (1988)

38. Andres, J.L., K. Stanley, S. Cheifetz & J. Massague: Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. J. Cell Biol. 109, 3137-3145 (1989)

39. Cheifetz, S., J.L. Andres and J. Massague: The transforming growth factor-beta receptor type III is a membrane proteoglycan; domain structure of the receptor. J. Biol. Chem. 263, 16984-16991 (1988)

40. Lopez-Casillas, F., H.M. Payne, J.L. Andres & J. Massague: Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J. Cell Biol. 124, 557-568 (1994)

41. Sankar, S., N. Mahooti-Brooks, M. Centrella, T.L. McCarthy & J.A. Madri: Expression of transforming growth factor beta type III receptor in bovine endothelial cells increases their responsiveness to transforming growth factor beta2. J. Biol. Chem. 270, 13567-13572 (1995)

42. Cheifetz, S., N. Ling, R. Guillemin & J. Massague: A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin. J. Biol. Chem. 263, 17225-17228 (1988)

43. Mathews, L.S. & W.W. Vale: Characterization of type II activin receptors: binding, processing and phosphorylation. J. Biol. Chem. 268, 19013-19018 (1993)

44. Attisano, L., J. Carcamo, F. Ventura, F.M.B. Weis, J. Massague, & J.L. Wrana: Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75, 671-680 (1993)

45. Centrella, M., S. Casinghino, C. Gundberg, T.L. McCarthy, J. Wozney & V. Rosen: Changes in bone morphogenetic protein (BMP) sensitivity relative to differentiation in fetal rat bone cell cultures. Ann. NY Acad. Sci. 785, 224-226 (1996)

46. Franzen, P. , P. tenDijke, H. Ichijo, H. Yamashita, P. Schulz, C.-H. Heldin & K. Miyazono: Cloning of a TGFbeta type I receptor that forms a heteromeric complex with the TGFbeta type II receptor. Cell 68, 681-692 (1993)

47. Estevez, M., L. Attisano, J.L. Wrana, P.S. Albert, J. Massague & D.L. Riddle: The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature(London) 365, 644-649 (1993)

48. Nellen, D., M. Affolter & K. Basler: Receptor serine/threonine kinases implicated in the control of Drosophila body pattern by decapentaplegic. Cell 78, 225-237 (1994)

49. Penton, A., Y. Chen, K. Staehling-Hampton, J.L. Wrana, L. Attisano, L., J. Szidonya, J.A. Cassill, J. Massague & F.M. Hoffman: Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell 78, 239-250 (1994)

50. Brummel, T.J., V. Twombly, G. Marques, J.L. Wrana, S.J. Newfeld, L. Attisano, J. Massague, M.B. O'Connor & W.M. Gelbart: Characterization and relationship of dpp receptors encoded by the saxophone and thick vein genes in Drosophila. Cell 78, 251-261 (1994)

51. tenDijke, P., H. Yamashita, T.K. Sampath, A.H. Reddi, M. Estevez, M., D.L. Riddle, H. Ichijo, C.-H. Heldin & K. Miyazono: Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269, 16985-16988 (1994)

52. Rizzino, A.: Appearance of high affinity receptors for type beta transforming growth factor during differentiation of murine embryonal carcinoma cells. Cancer Research 47, 4386-4390 (1987)

53. Ewton, D.Z., G. Spizz, E.N. Olson & J.R. Florini: Decrease in transforming growth factor-beta binding and action during

differentiation in muscle cells. J. Biol. Chem. 263, 4029-4032 (1988)

54. Kypriaou, N. & J. Isaacs: Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens. Endocrinology 123, 2124-2131 (1988)

55. Cochet, C., J.J. Feige, J.J. & E.M. Chambaz: Bovine adrenocortical cells exhibit high affinity transforming growth factor-beta receptors which are regulated by adrenocorticotropin. J. Biol. Chem. 263, 5707-5713 (1988)

56. Gazit, D., R. Ebner, A.J. Kahn & R. Derynck: Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol. Endocrinol. 7, 189-198 (1993)

57. Hu, J.-S. & E.N. Olson: Functional receptors for transforming growth factor-betae retained by biochemically differentiated C2 myocytes in growth factor deficient medium containing EGTA, but down-regulated during terminal differentiation. J. Biol. Chem. 265, 7914-7919 (1990)

58. Centrella, M., E. Canalis, T.L. McCarthy, J.J. Orloff, A.F. Stewart & K.L. Insogna: Parathyroid hormone-related protein modulates the effects of transforming growth factor beta on deoxyribonucleic acid and collagen synthesis in fetal rat bone cells. Endocrinology 125, 199-208 (1989)

59. Lopez-Casillas, F., S. Cheifetz, J. Doody, J.L. Andres, W.S. Lane & J. Massague: Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67, 785-795 (1991)

60. Wang, X.-F., H.Y. Lin, E. Ng-Eaton, J. Downward, H.F. Lodish & R.A. Weinberg: Expression cloning and characterization of the TGF-beta type III receptor. Cell 67, 797-805 (1991)

61. Bassing, C.H., J.M. Yingling, D.J. Howe, T. Wang, W.W. He, M.L. Gustafson, P. Shah, P.K. Donahoe & X.-F. Wang: A transforming growth factor beta type I receptor that signals to activate gene expression. Science 263, 87-89 (1994)

62. Humphries, D.E., B.B. Bloom, A. Fine & R.H. Goldstein: Structure and expression of the promoter for the human type II transforming growth factor-beta receptor. Biochem. Biophys. Res. Commun. 203, 1020-1027 (1994)

63. Bae, H.W., A.G. Geiser, D.H. Kim, M.T. Chung, J.K. Burmester, M.B. Sporn, A.B. Roberts & S.-J. Kim: Characterization of the promoter region of the human transforming growth factor-beta type II receptor gene. J. Biol. Chem. 270, 29460-29468 (1995)

64. Ji, C., S. Casinghino, T.L. McCarthy & M. Centrella: Cloning, characterization and expression of a rat transforming growth factor-beta type I receptor promoter. J. Cell. Biochem. 63:478-492 (1996)

65. Noda, M. & J.J. Camilliere: In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124, 2991-2994 (1989)

66. Marcelli, C., A.J. Yates & G.R. Mundy: In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. J. Bone Mineral Res. 5, 1087-1096 (1990)

67. Beck, L.S., A.J. Ammann, A.J., T.B. Aufdemorte, L. Deguzman, Y. Xu, W.P. Lee, L.A. McFatridge & T.L. Chen: In vivo induction of bone by recombinant human transforming growth factor beta1. J. Bone Mineral Res. 6, 961-968 (1991)

68. Centrella, M.: Growth factor receptors and responses: Comparison between normal and osteosarcoma-derived cell cultures. In: Frontiers in osteosarcoma research. Eds. Novak, J.F., McMaster, J.H.. Hogrefe and Huber, Inc., Toronto, Canada. 457-468 (1993)

69. Centrella, M., T.L. McCarthy & E. Canalis: Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat calvariae. J. Biol. Chem. 262, 2869-2874 (1987)

70. Hock, J., E. Canalis & M. Centrella: Transforming growth factor beta (TGFbeta-1) stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 126, 421-426 (1990)

71. Centrella, M., S. Casinghino, R. Ignotz & T.L. McCarthy: Multiple regulatory effects by transforming growth factor type b (TGF-beta1) on type I collagen levels in osteoblast-enriched cultures from fetal rat bone. Endocrinology 131, 2863-2872 (1992)

72. Strong, D.D., A.L. Beachler, J.E. Wergedal & T.A. Linkhart: Insulinlike growth factor II and transforming growth factor beta regulate collagen expression in human osteoblastlike cells in vitro. J. Bone Miner. Res. 6, 15-23 (1991)

73. Centrella, M., C. Ji, S. Casinghino & T.L. McCarthy: Rapid flux in transforming growth factor beta receptors on bone cells. J. Biol. Chem. 271, 18616-18622 (1996)

74. tenDijke, P., K.K. Iwata, C. Goddard, C. Pieler, E. Canalis, T.L. McCarthy & M. Centrella: Recombinant transforming growth factor type beta3: Biological activities and receptor binding properties in isolated bone cells. Mol. Cell. Biol. 10, 4473-4479 (1990)

75. Graycar, J.L., D.A. Miller, B.A. Arrcik, R.M. Lyons, H.L. Moses & R. Derynck: Human transforming growth factor beta3: recombinant expression, purification, and biological activities in comparison with transforming growth factors beta1 and beta2. Mol.

Endocrinol. 3, 1977-1986 (1989)

76. Takeuchi, Y., S. Fukumoto & T. Matsumoto: Relationship between actions of transforming growth factor (TGF-)beta and cell surface expression of its receptors in clonal osteoblastic cells. J. Cell. Physiol. 162, 315-321 (1995)

77. Takeuchi, Y., K. Nakayama & T. Matsumoto: Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells. J. Biol. Chem. 271, 3938-3944 (1996)

78. Iseki, S., N. Osumi-Yamashita, K. Miyazano, P. Franzen, H. Ichijo, H. Ohtani, Y. Hatashi & K. Eto: Localization of transforming growth factor-beta type I and type II receptors in mouse development. Exp. Cell. Res. 219, 339-347 (1995)

79. Iimura, T., S. Oida, H. Ichijo, M. Goseki, Y. Maruoka, K. Takeda, S. Sasaki: Modulation of responses to TGF-beta by 1,25 dihydroxyvitamin D3 in MG-63 osteoblastic cells: possible involvement of regulation of TGF-beta type II receptor. Biochem. Biophys. Res. Commun. 204, 918-923 (1994)

80. Nakayama, H., F. Ichikawa, J.L. Andres, J. Massague & M. Noda: Dexamethasone enhancement of betaglycan (TGF-beta type III receptor) gene expression in osteoblast-like cells. Exp. Cell. Res. 211, 301-306 (1994)

81. Sankar, S., N. Mahooti-Brooks, T.L. McCarthy, M. Centrella & J.A. Madri: Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest. 97, 1436-1446 (1996)

82. Yamaguchi, A., T. Katagiri, T. Ikeda, J.M. Wozney, V. Rosen, E.A. Wang, A.J. Kahn, T. Suda & S. Yoshiki: Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113, 681-687 (1991)

83. Hiraki, Y., H. Inoue, C. Shigeno, Y. Sanma, H. Bentz, D.M. Rosen, A. Asada & F. Suzuki: Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J. Bone Mineral Res. 6, 1373-1385 (1991)

84. Chen, T.L., R.L. Bates, A. Dudley, R.G. Hammonds & E.P. Amento: Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: comparison with TGF-beta1. J. Bone Mineral Res.6:1387-1393 (1991)

85. Thies, R.S., M. Bauduy, B.A. Ashton, L. Kurtzberg, J.M. Wozney & V. Rosen: Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130, 1318-1324 (1992)

86. Rosen, V., J. Nove, J.J. Song, R.S. Thies, K. Cox & J.M. Wozney: Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J. Bone Mineral Res. 9, 1759-1768 (1994)

87. Centrella, M., T.L. McCarthy & E. Canalis: Current Concepts Review: transforming growth factor-beta (TGF-beta) and remodeling of bone. J. Bone and Joint Res. 73-A, 1418-1428 (1991)

88. Carrington, J.L. & A.H. Reddi: Temporal changes in the response of chick limb bud mesodermal cells to transforming growth factor beta-type 1. Exp. Cell Res. 186, 368-373 (1990)

89. Carrington, J.L., P. Chen, M. Yanagishita & A.H. Reddi: Osteogenin (bone morphogenetic protein-3) stimulates cartilage formation by chick limb bud cells in vitro. Dev. Biol. 146, 406-415 (1991)

90. Chen, P., J.L. Carrington, R.G. Hammonds & A.H. Reddi: Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta1 and beta2. Exp. Cell Res. 195, 509-515 (1991)

91. Chen, P., J.L. Carrington, V.M. Paralkar, G.F. Pierce & A.H. Reddi: Chick limb bud mesodermal cell chondrogenesis: inhibition by isoforms of platelet-derived growth factor and reversal by recombinant bone morphogenetic protein. Exp. Cell Res. 200, 110-117 (1992)

92. Niswander, L. & G.R. Martin: FGF-4 and BMP-2 have opposite effects on limb growth. Nature (London) 361, 68-71 (1993)

93. Kingsley, D.M., A.E. Bland, J.M. Grubber, P.C. Merker, L.B. Russell, N.G. Copeland & N.A. Jenkins: The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 71, 399-410 (1992)

94. Centrella, M., V. Rosen, J.M. Wozney, S.R. Casinghino & T.L. McCarthy: Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures. J. Cellular Biochem. 67, 528-540 (1997)

95. Bloom, B.B., D.E. Humphries, P.-P. Kuang, A. Fine & R.H. Goldstein: Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: regulation by TGF-beta. Biochim. Biophys. Acta 1312, 243-248 (1996)

96. Ji, C., S. Casinghino, T.L. McCarthy & M. Centrella: Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor. J. Biol. Chem. 272, 21260-21267 (1997)

97. Saffer, J.D., S.P. Jackson & M.B. Annarella: Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11, 2189-2199 (1991)

98. Ji, C., S. Casinghino, D.J. Chang, Y. Chen, A. Javed, Y. Ito, S.W. Hiebert, J.B. Lian, G.S. Stein, T.L. McCarthy & M. Centrella: CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem (In Press)

99. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada & Y. Ito: PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90, 6859-6863 (1993)

100. Ogawa, E., M. Inuzuka, M. Maruyama, M. Satake, M. Naito-Fujimoto, Y. Ito & K. Shigesada: Molecular cloning and characterization of PEBP2beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 . Virology 194, 314-331 (1993)

101. Bae, S.-C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K. Shigesada, N.A. Jenkins, D.J. Gilbert, N.C. Copeland & Y. Ito: PEBP2alphaB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 14, 3242-3252 (1994)

102. Levanon, D., V. Negreanu, Y. Berstein, I. Bar-Am, L. Avivi & Y. Groner: AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23, 425-432 (1994)

103. Tanaka, T., K. Mineo, K. Ueki, K. Tanaka, Y. Imai, K. Mitani, K. Okazaki, N. Sagata, Y. Yazaki, Y. Shibata, T. Kadowaki & H. Hirai: The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell. Biol. 16, 3967-3979 (1996)

104. Satake, M., T. Ibaraki, Y. Yamaguchi & Y. Ito: Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene. J. Virology 63, 3669-3677 (1989)

105. Zhang, D.-R., C.J. Hetherington, S. Meyers, K.L. Rhoades, C.J. Larson, H.-M. Chen, S.W. Hiebert & D.G. Tenen: CCAAT enhancer binding protein (C/EBP) and AML-1 (CBFalpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16, 1231-1240 (1996)

106. Oelgeschlager, M., I. Nuchprayoon, B. Luscher & A.D. Friedman: C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol. 16, 4717-4725 (1996)

107. Britos-Bray, M. & A.D. Friedman: Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb. Mol. Cell. Biol. 17, 5127-5135 (1997)

108. Umayahara, Y., C. Ji, M. Centrella, P. Rotwein & T.L. McCarthy: CCAAT/enhancer binding protein delta (C/EBPdelta) activates insulin-like growth factor-I gene transcription in osteoblasts: identification of a novel cyclic AMP signaling pathway in bone. J. Biol. Chem. 272, 31793-31800 (1997)

109. Miyoshi, H., M. Ohira, K. Shimizu, K. Mitani, H. Hirai, T. Imai, K. Yokoyama, E. Soeda & M. Ohki: Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nuc. Acids Res. 23, 2762-2769 (1995)

110. Meyers, S., N. Lenny & S.W. Hiebert: The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15, 1974-1982 (1995)

111. Zhang, Y.-W., S.-C. Bae, G. Huang, Y.-X. Fu, J. Lu, M.-Y. Ahn, Y. Kanno & Y. Ito: A novel transcript encoding an n-terminally truncated AML1/PEBP2alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dc13 myeloid cells. Mol. Cell. Biol. 17, 4133-4145 (1997)

112. Zhu, X., J.E. Yeadon & S.J. Burden: AML1 is expressed in skeletal muscle and is regulated by innervation. Mol. Cell. Biol. 14, 8051-8057 (1994)

113. Merriman, H.L., A.J. van Wijnene, S. Hiebert, J.P. Bidwell, E. Fey, J. Lian, J. Stein & G.S. Stein: The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 34, 13125-13132 (1995)

114. Ducy, P. & G. Karsenty: Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15, 1858-1869 (1995)

115. Geoffrey, V., P. Ducy & G. Karsenty: A PEBP2 alpha/AML1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J. Biol. Chem. 270, 30973-30979 (1995)

116. Banerjee, C., S.W. Hiebert, J.L. Stein, J.B. Lian & G.S. Stein: An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc. Natl. Acad. Sci. USA 93, 4968-4973 (1996)

117. Banerjee, C., L.R. McCabe, J.-Y. Choi, S.W. Hiebert, J.L. Stein, G.S. Stein & J.B. Lian: Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cellular Biochem. 66, 1-8 (1997)

118. Ducy, P., R. Zhang, V. Geoffrey, A.L. Ridall & G. Karsenty: Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754 (1997)

119. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.-H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki & T. Kishimoto: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 (1997)

120. Otto, F., A.P. Thornell, T. Crompton, A. Denzel, K.C. Gilmour, I.R. Rosewell, G. W. H. Stamp, R. S. P. Beddington, S. Mundlos, B.R. Olsen, P.B. Selby & M.J. Owen: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 (1997)

121. Mundlos, S., F. Otto, C. Mundlos, J.B. Mulliken, A.S. Aylsworth, S. Albright, D. Lindhout, W. G. Cole, W. Henn, J. H. M. Knoll, M.J. Owen, R. Mertelsmann, B.U. Zabel & B.R. Olsen: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779 (1997)

122. Chang, D.J., C. Ji, K.K. Kim, S. Casinghino, T.L. McCarthy & M. Centrella: Reduction in CBFa1 and TGF-beta receptor I on bone cells by glucocorticoid. J. Biol. Chem. 273, (1998, in press)